234 related articles for article (PubMed ID: 6606442)
41. [Cellular immunologic examination in suspected immunodeficiency. Presentation of a laboratory material].
Egeland T; Mellbye OJ
Tidsskr Nor Laegeforen; 1987 Nov; 107(31):2759-62. PubMed ID: 3424315
[No Abstract] [Full Text] [Related]
42. [Derangement of host defense--immunodeficiency (author's transl)].
Matsumoto S
Hokkaido Igaku Zasshi; 1979; 54(2):125-8. PubMed ID: 314927
[No Abstract] [Full Text] [Related]
43. Lack of interleukin-2 production in a patient with OKT4+ T-cell deficiency.
Tsuchiya S; Imaizumi M; Minegishi M; Konno T; Tada K
N Engl J Med; 1983 May; 308(21):1294. PubMed ID: 6601773
[No Abstract] [Full Text] [Related]
44. The role of thymosin in lymphocyte maturation.
Thurman GB; Goldstein AL
Boll Ist Sieroter Milan; 1975 Jul; 54(3):203-10. PubMed ID: 1082758
[No Abstract] [Full Text] [Related]
45. T-cell subsets and natural killer cells in DiGeorge and SCID patients.
Sirianni MC; Businco L; Fiore L; Seminara R; Aiuti F
Birth Defects Orig Artic Ser; 1983; 19(3):107-8. PubMed ID: 6606443
[No Abstract] [Full Text] [Related]
46. [The potential of using low-frequency ultrasound for the correction of immunodeficiency states].
Sologub EN; Siziakina LP; Moskalenko EP
Vopr Kurortol Fizioter Lech Fiz Kult; 1991; (1):44-6. PubMed ID: 2048298
[No Abstract] [Full Text] [Related]
47. [Disorders of cellular immunity in asthma and other allergic diseases].
Rowińska-Zakrzewska E
Pneumonol Pol; 1980 Jun; 48(6):407-13. PubMed ID: 6995950
[No Abstract] [Full Text] [Related]
48. [Variable immunodeficiency (author's transl)].
Anguita T; Pinto R; Aguilera B; Daiber A; Mocarquer A
Rev Med Chil; 1978 Feb; 106(2):115-7. PubMed ID: 306653
[No Abstract] [Full Text] [Related]
49. In vitro and in vivo responses to thymosin in severe combined immunodeficiency.
Mawhinney H; Gleadhill VF; McCrea S
Clin Immunol Immunopathol; 1979 Oct; 14(2):196-203. PubMed ID: 314879
[No Abstract] [Full Text] [Related]
50. Hormonal influences on the reticuloendothelial system: current status of the role of thymosin in the regulation and modulation of immunity.
Goldstein AL; Thurman GB; Low TL; Rossio JL; Trivers GE
J Reticuloendothel Soc; 1978 Apr; 23(4):253-66. PubMed ID: 353275
[No Abstract] [Full Text] [Related]
51. [Severe congenital immune deficiency with primary defect of the cell-mediated immune response].
Tímár L; Budai J
Orv Hetil; 1986 Jul; 127(27):1625-30. PubMed ID: 3488534
[No Abstract] [Full Text] [Related]
52. Molecular defects in T- and B-cell primary immunodeficiency diseases.
Cunningham-Rundles C; Ponda PP
Nat Rev Immunol; 2005 Nov; 5(11):880-92. PubMed ID: 16261175
[TBL] [Abstract][Full Text] [Related]
53. Host defense mechanisms and aging.
Schwab R; Walters CA; Weksler ME
Semin Oncol; 1989 Feb; 16(1):20-7. PubMed ID: 2645645
[No Abstract] [Full Text] [Related]
54. [The concept of immunocorrection in multifactor immunodeficiency states, infectious and cancerous diseases].
Kuznetsov VP; Beliaev DL; Babaiants AA
Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):104-10. PubMed ID: 9082712
[No Abstract] [Full Text] [Related]
55. [The immunodeficiency state and the efficacy of the glucocorticoid therapy of patients with glomerulonephritis and the nephrotic syndrome].
Kolesnyk MO; Dorets'kyĭ VV
Lik Sprava; 1992; (11-12):53-5. PubMed ID: 1292222
[TBL] [Abstract][Full Text] [Related]
56. Induction of responsiveness in lymphocytes of immunodeficient patients' cells implanted with foreign plasma membranes.
Levy D; Porat Y; Pick I; Handzel ZT; Schlesinger M; Tanay A; Zan-Bar I
Immunodeficiency; 1993; 4(1-4):43-6. PubMed ID: 8167731
[No Abstract] [Full Text] [Related]
57. Deficiency of OKT4+ helper cells in SCID.
Conley ME; Nowell PC; Henle G; Douglas SD
J Pediatr; 1985 Jan; 106(1):169-70. PubMed ID: 3155549
[No Abstract] [Full Text] [Related]
58. [Transfer factor and its therapeutic use].
Rosenthal M
Schweiz Med Wochenschr; 1974 Oct; 104(43):1501-6. PubMed ID: 4549135
[No Abstract] [Full Text] [Related]
59. Necrotic ulceration of the nose in a patient with primary immunodeficiency syndrome characterized by severe defects in the production of cytokines.
Koch C; Pedersen FK; Bendtzen K; Ryder L
Immunodeficiency; 1993; 4(1-4):141-4. PubMed ID: 8167689
[No Abstract] [Full Text] [Related]
60. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.
Goldstein AL; Cohen GH; Rossio JL; Thurman GB; Brown CN; Ulrich JT
Med Clin North Am; 1976 May; 60(3):591-606. PubMed ID: 131889
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
